CORRESPONDENCE|
June 1, 1992
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia [letter]
Blood (1992) 79 (11): 3091–3092.
